Reactive arthritis after COVID-19.
Anti-Inflammatory Agents
/ administration & dosage
Anti-Inflammatory Agents, Non-Steroidal
/ administration & dosage
Arthralgia
/ diagnosis
Arthritis
/ drug therapy
Arthritis, Reactive
/ diagnosis
Arthritis, Rheumatoid
/ diagnosis
Autoantibodies
/ analysis
COVID-19
/ complications
Diagnosis, Differential
Humans
Knee Joint
/ diagnostic imaging
Lower Extremity
/ pathology
Male
Middle Aged
Prednisolone
/ administration & dosage
Radiography
/ methods
Synovial Fluid
/ cytology
Treatment Outcome
COVID-19
immunology
rheumatology
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
02 Mar 2021
02 Mar 2021
Historique:
entrez:
3
3
2021
pubmed:
4
3
2021
medline:
11
3
2021
Statut:
epublish
Résumé
A previously healthy 53-year-old man was hospitalised for 12 days due to COVID-19 with shortness of breath. A few days after discharge from hospital, the patient developed fever and severe pain in several joints in the lower extremities. The pain was so severe that the patient was unable to stand on his feet. Synovial fluid from the right-side knee contained a high number of polynuclear cells and a few mononuclear cells. Microscopy, culture and PCR tests for bacterial infection were all negative. Furthermore, the patient tested negative for rheumatoid factor, anti-cyclic citrullinated peptide and human leukocyte antigen (HLA)-B27. Thus, the condition was compatible with reactive arthritis. The condition improved markedly after a few days' treatment with non-steroid anti-inflammatory drugs and prednisolone.
Identifiants
pubmed: 33653867
pii: 14/3/e241375
doi: 10.1136/bcr-2020-241375
pmc: PMC7929821
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Anti-Inflammatory Agents, Non-Steroidal
0
Autoantibodies
0
Prednisolone
9PHQ9Y1OLM
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Clin Rheumatol. 2020 Sep;26(6):233
pubmed: 32694352
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Lancet. 2010 Mar 6;375(9717):846-55
pubmed: 20206778
RMD Open. 2020 Aug;6(2):
pubmed: 32763956
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
J Med Virol. 2021 Jan;93(1):192-193
pubmed: 32652541
Ann Rheum Dis. 2020 Jun 26;:
pubmed: 32591356
Curr Rheumatol Rep. 2020 May 26;22(7):29
pubmed: 32458153